2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
211
Triple Negative Breast Neoplasms
32
Stomach Neoplasms
32
Inflammatory Breast Neoplasms
21
Esophageal Neoplasms
16
Carcinoma, Hepatocellular
15
Lymphoma, Large B-Cell, Diffuse
9
Sarcoma
8
Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
6
Urinary Bladder Neoplasms
5
Pancreatic Neoplasms
5
Liver Neoplasms
5
Breast Neoplasms, Male
5
Adenocarcinoma Of Esophagus
5
Ovarian Neoplasms
4
Lymphoma
4
Testicular Neoplasms
3
Primary Breast Cancer
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Hemangiosarcoma
3
Gallbladder Neoplasms
3
Carcinoma, Ductal, Breast
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Recurrence
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplastic Cells, Circulating
2
Interventions
Fluorouracil
219
Leucovorin
202
Oxaliplatin
192
Irinotecan
150
Bevacizumab
110
Capecitabine
94
Cetuximab
90
Folfox protocol
54
Chemotherapy, Adjuvant
36
Panitumumab
30
Colonoscopy
30
pembrolizumab
23
Drug Therapy
23
Nivolumab
22
Magnetic Resonance Spectroscopy
22
Gemcitabine
21
Blood Specimen Collection
20
Radiotherapy
19
Floxuridine
19
Biopsy
19
Neoadjuvant Therapy
18
Laparoscopy
18
IFL protocol
18
Early Intervention, Educational
18
Celecoxib
18
Surveys and Questionnaires
17
Surgical Procedures, Operative
16
Immunohistochemistry
16
Exercise
16
trifluridine tipiracil drug combination
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Epirubicin
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled